Myeloperoxidase and nitroblue tetrazolium reducing activity in 32Dcl3 and 32D/ε cells
| Cells . | MPO (%) . | NBT (%) . |
|---|---|---|
| 32Dcl3 | ||
| IL-3 | 0 ± 0 | 10.3 ± 2.1 |
| G-CSF | 0 ± 0 | 50.3 ± 2.5 |
| 32D/ε | ||
| IL-3 | 46.0 ± 4.6 | 60.0 ± 7.2 |
| G-CSF | 86.7 ± 4.2 | 95.3 ± 2.5 |
| Cells . | MPO (%) . | NBT (%) . |
|---|---|---|
| 32Dcl3 | ||
| IL-3 | 0 ± 0 | 10.3 ± 2.1 |
| G-CSF | 0 ± 0 | 50.3 ± 2.5 |
| 32D/ε | ||
| IL-3 | 46.0 ± 4.6 | 60.0 ± 7.2 |
| G-CSF | 86.7 ± 4.2 | 95.3 ± 2.5 |
Values are the mean ± SD percentages of cells positive for MPO or NBT from 3 independent experiments. Cells were treated with G-CSF for 3 days.
MPO indicates myeloperoxidase; NBT, nitroblue tetrazolium. See Table 1for other abbreviations.